Tower Research Capital LLC (TRC)
Position in AVIR — Atea Pharmaceuticals, Inc.
CIK 1533421
NEW YORK, NY
Position in AVIR
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$28,843
+$7,544 QoQ
Shares Held
6,203
+56.7% QoQ
Ownership
0.008%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#91
of 125 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AVIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. AVIR ranks #192 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in AVIR
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $28,843 | 6,203 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $21,299 | 3,959 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $9,603 | 2,690 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $15,442 | 5,325 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $30,571 | 8,492 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $64,093 | 21,436 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $12,116 | 3,617 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $39,308 | 11,734 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $31,385 | 9,482 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $5,938 | 1,470 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $92,537 | 30,340 | Shares | Defined | 2024-02-13 | |
| 2023-09-30 | $39,894 | 13,298 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $21,489 | 5,746 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $10,572 | 3,156 | Shares | Defined | 2023-05-09 | |
| 2022-12-31 | $101,221 | 21,044 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $101,310 | 17,805 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $166,864 | 23,502 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $9,378 | 1,299 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $11,201 | 1,253 | Shares | Other | 2022-02-14 | |
| 2021-09-30 | $231,009 | 6,589 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $36,107 | 1,681 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $45,015 | 729 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $13,870 | 332 | Shares | Defined | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||